Evidence map›Paper›PMID 39330888›Full record

ReviewTropical medicine and infectious disease2024

Diagnosis and Management of Neonatal Bacterial Sepsis: Current Challenges and Future Perspectives.

Domenico Umberto De Rose, Maria Paola Ronchetti, Ludovica Martini, Jole Rechichi, Marco Iannetta, Andrea Dotta, Cinzia Auriti

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Domenico Umberto De RoseNeonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, 00165 Rome, Italy.ORCID 0000-0002-9076-9838
Maria Paola RonchettiNeonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, 00165 Rome, Italy.
Ludovica MartiniNeonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, 00165 Rome, Italy.ORCID 0000-0002-3090-5949
Jole RechichiNeonatal Sub-Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, 00165 Rome, Italy.
Marco IannettaInfectious Disease Clinic, Policlinico "Tor Vergata" University Hospital, 00133 Rome, Italy.ORCID 0000-0002-6938-8627
Andrea DottaNeonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, 00165 Rome, Italy.ORCID 0000-0002-1260-6427
Cinzia AuritiPediatrics Department, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.

Funding

Ministero della Salute Current Research funds
6 · The paper itself

Abstract

Sepsis remains the second cause of death among neonates after the pathological consequences of extreme prematurity. In this review we summarized knowledge about pathogens causing early-onset sepsis (EOS) and late-onset sepsis (LOS), the role of perinatal risk factors in determining the EOS risk, and the tools used to reduce unnecessary antibiotics. New molecular assays could improve the accuracy of standard blood cultures, providing the opportunity for a quick and sensitive tool. Different sepsis criteria and biomarkers are available to date, but further research is needed to guide the use of antibiotics according to these tools. Beyond the historical antibiotic regimens in EOS and LOS episodes, antibiotics should be based on the local flora and promptly modulated if specific pathogens are identified. The possibility of an antibiotic lock therapy for central venous catheters should be further investigated. In the near future, artificial intelligence could help us to personalize treatments and reduce the increasing trend of multidrug-resistant bacteria.

Indexed as

antibiotic lock therapybiomarkersblood culturec-reactive proteinearly-onset sepsislate-onset sepsisPCR assayspresepsinprocalcitoninsepsis calculator

Identifiers

PMID39330888
PMCPMC11435811

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.